In the present study, we provide the evidences that FOXM1 and its direct downstream DNA repair gene EXO1 might play in increasing the survival of ovarian cancer cells after cisplatin treatment, and targeting FOXM1/EXO1 axis can sensitize ovarian cancer cell to cisplatin treatment. The gene discussed is EXO1; the disease is ovarian cancer.